Ensign Peak Advisors’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,590
Closed -$187K 1859
2022
Q3
$187K Buy
6,590
+5,800
+734% +$149K ﹤0.01% 1900
2022
Q2
$16K Hold
790
﹤0.01% 2136
2022
Q1
$17K Buy
+790
New +$17.1K ﹤0.01% 2183
2021
Q4
Sell
-37,038
Closed -$787K 2203
2021
Q3
$787K Hold
37,038
﹤0.01% 1509
2021
Q2
$611K Hold
37,038
﹤0.01% 1557
2021
Q1
$463K Hold
37,038
﹤0.01% 1607
2020
Q4
$329K Sell
37,038
-6,400
-15% -$52.1K ﹤0.01% 1667
2020
Q3
$282K Hold
43,438
﹤0.01% 1633
2020
Q2
$268K Hold
43,438
﹤0.01% 1549
2020
Q1
$293K Hold
43,438
﹤0.01% 1484
2019
Q4
$505K Buy
+43,438
New +$490K ﹤0.01% 1504

Other funds holding CCRN

Ensign Peak Advisors's CCRN Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Cross Country Healthcare (CCRN) in Q4 2022, closing a stake of 6,590 shares — an estimated $187K sold.

Ensign Peak Advisors first reported a position in CCRN in Q4 2019 and held it in 11 quarters. The position peaked at $787K in Q3 2021. 232 funds tracked by Wall St. Rank hold CCRN as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Cross Country Healthcare position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 6,590 Cross Country Healthcare shares in Q4 2022, an estimated $187K.
  • Ensign Peak Advisors first reported a position in Cross Country Healthcare in Q4 2019 and held it in 11 quarters.
  • Ensign Peak Advisors's Cross Country Healthcare position peaked at $787K in Q3 2021.
  • 232 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.